Analysis of the plasma proteome using iTRAQ and TMT-based Isobaric labeling.
暂无分享,去创建一个
Riitta Lahesmaa | David R Goodlett | Robert Moulder | D. Goodlett | R. Lahesmaa | R. Moulder | Santosh D Bhosale | S. D. Bhosale
[1] Paul Bowness,et al. Discovery of Candidate Serum Proteomic and Metabolomic Biomarkers in Ankylosing Spondylitis* , 2011, Molecular & Cellular Proteomics.
[2] Peter Rossing,et al. Quantitative iTRAQ-Based Proteomic Identification of Candidate Biomarkers for Diabetic Nephropathy in Plasma of Type 1 Diabetic Patients , 2010, Clinical Proteomics.
[3] H. Gabra,et al. Identification of proteomic and metabolic signatures associated with chemoresistance of human epithelial ovarian cancer. , 2016, International journal of oncology.
[4] H. Ressom,et al. iTRAQ-based quantitative protein expression profiling and MRM verification of markers in type 2 diabetes. , 2012, Journal of proteome research.
[5] Karl Mechtler,et al. Peptide Labeling with Isobaric Tags Yields Higher Identification Rates Using iTRAQ 4-Plex Compared to TMT 6-Plex and iTRAQ 8-Plex on LTQ Orbitrap , 2010, Analytical chemistry.
[6] M. Kasuga,et al. Differential proteome analysis of serum proteins associated with the development of type 2 diabetes mellitus in the KK-A(y) mouse model using the iTRAQ technique. , 2013, Journal of proteomics.
[7] Hai‐Tao Hou,et al. Plasma Proteomic Study in Pulmonary Arterial Hypertension Associated with Congenital Heart Diseases , 2016, Scientific Reports.
[8] J. Ping,et al. Comparative serum proteomic analysis of adenomyosis using the isobaric tags for relative and absolute quantitation technique. , 2013, Fertility and sterility.
[9] M. I. Mora,et al. Multicentric study of the effect of pre-analytical variables in the quality of plasma samples stored in biobanks using different complementary proteomic methods. , 2017, Journal of proteomics.
[10] Dana Pascovici,et al. Quantitative Age-specific Variability of Plasma Proteins in Healthy Neonates, Children and Adults* , 2017, Molecular & Cellular Proteomics.
[11] G. Clifton,et al. Identification of serum biomarkers in brain-injured adults: potential for predicting elevated intracranial pressure. , 2008, Journal of neurotrauma.
[12] J. Rajapakse,et al. Serum Proteome and Cytokine Analysis in a Longitudinal Cohort of Adults with Primary Dengue Infection Reveals Predictive Markers of DHF , 2012, PLoS neglected tropical diseases.
[13] D. Tuveson,et al. Decreased Serum Thrombospondin-1 Levels in Pancreatic Cancer Patients Up to 24 Months Prior to Clinical Diagnosis: Association with Diabetes Mellitus , 2015, Clinical Cancer Research.
[14] Ingo Ruczinski,et al. Plasma Proteome Biomarkers of Inflammation in School Aged Children in Nepal , 2015, PloS one.
[15] P. Xie,et al. Comparative proteomic analysis of plasma from major depressive patients: identification of proteins associated with lipid metabolism and immunoregulation. , 2012, The international journal of neuropsychopharmacology.
[16] P. Wright,et al. Quantitation with chemical tagging reagents in biomarker studies , 2015, Proteomics. Clinical applications.
[17] Kai A. Reidegeld,et al. Protein labeling by iTRAQ: A new tool for quantitative mass spectrometry in proteome research , 2007, Proteomics.
[18] H. Fox,et al. Comparison of 4-plex to 8-plex iTRAQ Quantitative Measurements of Proteins in Human Plasma Samples , 2012, Journal of proteome research.
[19] Jiye Ai,et al. Discovery of potential serum protein biomarkers for lymph node metastasis in oral cancer , 2016, Head & neck.
[20] M. Loh,et al. Upregulation of plasma C9 protein in gastric cancer patients , 2010, Proteomics.
[21] Hasmik Keshishian,et al. Quantitative, multiplexed workflow for deep analysis of human blood plasma and biomarker discovery by mass spectrometry , 2017, Nature Protocols.
[22] C. Corless,et al. Novel Biomarker Candidates to Predict Hepatic Fibrosis in Hepatitis C Identified by Serum Proteomics , 2011, Digestive Diseases and Sciences.
[23] Michael J. Walker,et al. Discovery and Validation of Predictive Biomarkers of Survival for Non-small Cell Lung Cancer Patients Undergoing Radical Radiotherapy: Two Proteins With Predictive Value , 2015, EBioMedicine.
[24] P. Jenö,et al. Quantitative Proteomic (iTRAQ) Analysis of 1st Trimester Maternal Plasma Samples in Pregnancies at Risk for Preeclampsia , 2012, Journal of biomedicine & biotechnology.
[25] Matthias Mann,et al. Proteomics reveals the effects of sustained weight loss on the human plasma proteome , 2016, Molecular systems biology.
[26] Ken-ichi Matsumoto,et al. Plasma proteomic changes during hypothermic and normothermic cardiopulmonary bypass in aortic surgeries , 2014, International journal of molecular medicine.
[27] Kelly A. Jones,et al. Assessment of two immunodepletion methods: off-target effects and variations in immunodepletion efficiency may confound plasma proteomics. , 2012, Journal of proteome research.
[28] A. Roses,et al. Identification of plasma biomarkers of TBI outcome using proteomic approaches in an APOE mouse model. , 2012, Journal of neurotrauma.
[29] J. Stulík,et al. Plasma concentration of fibronectin is decreased in patients with hypertrophic cardiomyopathy. , 2016, Clinica chimica acta; international journal of clinical chemistry.
[30] P. Xie,et al. Plasma-based proteomics reveals lipid metabolic and immunoregulatory dysregulation in post-stroke depression , 2014, European Psychiatry.
[31] J. Ping,et al. Serum differential proteomic analysis of endometriosis and adenomyosis by iTRAQ technique. , 2014, European journal of obstetrics, gynecology, and reproductive biology.
[32] T. Zhu,et al. Analysis of transcriptional factors and regulation networks in patients with acute renal allograft rejection. , 2011, Journal of proteome research.
[33] G. Ginsburg,et al. Discovery of biomarker candidates for coronary artery disease from an APOE‐knock out mouse model using iTRAQ‐based multiplex quantitative proteomics , 2011, Proteomics.
[34] J. Timms,et al. Quantitative profiling of serum samples using TMT protein labelling, fractionation and LC-MS/MS. , 2011, Methods.
[35] Dirk Valkenborg,et al. This item is the archived peer-reviewed author-version of: CONSTANd : a normalization method for isobaric labeled spectra by constrained optimization , 2022 .
[36] Ping Zhang,et al. A proteomic approach for plasma biomarker discovery with 8-plex iTRAQ labeling and SCX-LC-MS/MS , 2010, Molecular and Cellular Biochemistry.
[37] Xiaomin Song,et al. iTRAQ experimental design for plasma biomarker discovery. , 2008, Journal of proteome research.
[38] Akhilesh Pandey,et al. Identification of differentially expressed serum proteins in gastric adenocarcinoma. , 2015, Journal of proteomics.
[39] Y. Lau,et al. Identification of Protein Markers in Patients Infected with Plasmodium knowlesi, Plasmodium falciparum and Plasmodium vivax , 2014, International journal of molecular sciences.
[40] Andrew J. Percy,et al. Multiple Reaction Monitoring Enables Precise Quantification of 97 Proteins in Dried Blood Spots* , 2015, Molecular & Cellular Proteomics.
[41] L. Richeldi,et al. A Quantitative Proteomic Approach to Identify Significantly Altered Protein Networks in the Serum of Patients with Lymphangioleiomyomatosis (LAM) , 2014, PloS one.
[42] Kristin L Cheek,et al. Depletion of abundant plasma proteins and limitations of plasma proteomics. , 2010, Journal of proteome research.
[43] T. Naka,et al. Screening for novel serum biomarker for monitoring disease activity in rheumatoid arthritis using iTRAQ technology-based quantitative proteomic approach. , 2014, Methods in molecular biology.
[44] Josselin Noirel,et al. Minimising iTRAQ ratio compression through understanding LC‐MS elution dependence and high‐resolution HILIC fractionation , 2011, Proteomics.
[45] J. Rao,et al. Quantitative Proteomics Analysis by Isobaric Tags for Relative and Absolute Quantitation Identified Lumican as a Potential Marker for Acute Aortic Dissection , 2011, Journal of biomedicine & biotechnology.
[46] M. Larsen,et al. Plasma proteome profiling of atherosclerotic disease manifestations reveals elevated levels of the cytoskeletal protein vinculin. , 2014, Journal of proteomics.
[47] S. Carr,et al. A pipeline that integrates the discovery and verification of plasma protein biomarkers reveals candidate markers for cardiovascular disease , 2011, Nature Biotechnology.
[48] R. Cole,et al. The Plasma Proteome Identifies Expected and Novel Proteins Correlated with Micronutrient Status in Undernourished Nepalese Children 1 – 3 , 2013 .
[49] Unraveling biomarkers of abdominal aortic aneurisms by iTRAQ analysis of depleted plasma. , 2013, Methods in molecular biology.
[50] J. Lehtiö,et al. A novel prefractionation method combining protein and peptide isoelectric focusing in immobilized pH gradient strips. , 2013, Journal of proteome research.
[51] Jennifer K. Miller,et al. Quantitative Proteomics for Cardiac Biomarker Discovery Using Isoproterenol-Treated Nonhuman Primates , 2014, Journal of proteome research.
[52] Michelle A. Anderson,et al. Large-scale identification of core-fucosylated glycopeptide sites in pancreatic cancer serum using mass spectrometry. , 2015, Journal of proteome research.
[53] O. Krokhin,et al. Assessment of the reproducibility of random hexapeptide peptide library-based protein normalization. , 2010, Journal of proteome research.
[54] James R. Anderson,et al. Plasma proteomic analysis of simian immunodeficiency virus infection of rhesus macaques. , 2010, Journal of proteome research.
[55] Xi Liu,et al. Alpha-2-macroglobulin and heparin cofactor II and the vulnerability of carotid atherosclerotic plaques: An iTRAQ-based analysis. , 2017, Biochemical and biophysical research communications.
[56] R. Philip,et al. Investigation of plasma biomarkers in HIV-1/HCV mono- and coinfected individuals by multiplex iTRAQ quantitative proteomics. , 2011, Omics : a journal of integrative biology.
[57] Mark McEvoy,et al. Plasma protein profiling of mild cognitive impairment and Alzheimer's disease across two independent cohorts. , 2014, Journal of Alzheimer's disease : JAD.
[58] Yin-kun Liu,et al. High-throughput screening of tumor metastatic-related differential glycoprotein in hepatocellular carcinoma by iTRAQ combines lectin-related techniques , 2013, Medical Oncology.
[59] Shen Hu,et al. Quantitative Proteomic Analysis of Serum Proteins from Oral Cancer Patients: Comparison of Two Analytical Methods , 2014, International journal of molecular sciences.
[60] M. Stobiecki,et al. Optimization of Plasma Sample Pretreatment for Quantitative Analysis Using iTRAQ Labeling and LC-MALDI-TOF/TOF , 2014, PloS one.
[61] Ravi Sirdeshmukh,et al. Proteins with Altered Levels in Plasma from Glioblastoma Patients as Revealed by iTRAQ-Based Quantitative Proteomic Analysis , 2012, PloS one.
[62] M. Kussmann,et al. Comprehensive and Scalable Highly Automated MS-Based Proteomic Workflow for Clinical Biomarker Discovery in Human Plasma. , 2014, Journal of proteome research.
[63] Eithne Costello,et al. A technically detailed and pragmatic protocol for quantitative serum proteomics using iTRAQ. , 2009, Journal of proteomics.
[64] Ken-ichi Matsumoto,et al. Monitoring of Serial Presurgical and Postsurgical Changes in the Serum Proteome in a Series of Patients with Calcific Aortic Stenosis , 2015, Disease markers.
[65] D. Angus,et al. Proteomics reveals age-related differences in the host immune response to sepsis. , 2014, Journal of proteome research.
[66] Caroline Dive,et al. Statistical Considerations of Optimal Study Design for Human Plasma Proteomics and Biomarker Discovery , 2012, Journal of proteome research.
[67] Bruno Domon,et al. Large-Scale Targeted Proteomics Using Internal Standard Triggered-Parallel Reaction Monitoring (IS-PRM)* , 2015, Molecular & Cellular Proteomics.
[68] S. Sze,et al. Discovery of Prognostic Biomarker Candidates of Lacunar Infarction by Quantitative Proteomics of Microvesicles Enriched Plasma , 2014, PloS one.
[69] N. Gregersen,et al. Plasma and urine proteomic profiles in childhood idiopathic nephrotic syndrome , 2012, Proteomics. Clinical applications.
[70] Jennifer M. Campbell,et al. Semi-targeted plasma proteomics discovery workflow utilizing two-stage protein depletion and off-line LC-MALDI MS/MS. , 2011, Journal of proteome research.
[71] Olli Simell,et al. Serum Proteomes Distinguish Children Developing Type 1 Diabetes in a Cohort With HLA-Conferred Susceptibility , 2015, Diabetes.
[72] M. Dhaenens,et al. Comparative proteome analysis of porcine follicular fluid and serum reveals that excessive α2‐macroglobulin in serum hampers successful expansion of cumulus‐oocyte complexes , 2009, Proteomics.
[73] Andrew H. Thompson,et al. Tandem mass tags: a novel quantification strategy for comparative analysis of complex protein mixtures by MS/MS. , 2003, Analytical chemistry.
[74] Leo Uchida,et al. A Proteomic Approach Identifies Candidate Early Biomarkers to Predict Severe Dengue in Children , 2016, PLoS neglected tropical diseases.
[75] Li Li,et al. Proteomic analysis of serum of women with elevated Ca-125 to differentiate malignant from benign ovarian tumors. , 2012, Asian Pacific journal of cancer prevention : APJCP.
[76] Hoguen Kim,et al. Simple method for quantitative analysis of N-linked glycoproteins in hepatocellular carcinoma specimens. , 2010, Journal of proteome research.
[77] T. Libermann,et al. Identification of a novel potential biomarker in a model of hemorrhagic shock and valproic acid treatment. , 2010, The Journal of surgical research.
[78] T. Lawrence,et al. Quantitative Proteomic Analysis of Serum Exosomes from Patients with Locally Advanced Pancreatic Cancer Undergoing Chemoradiotherapy. , 2017, Journal of proteome research.
[79] B. McManus,et al. Plasma protein biosignatures for detection of cardiac allograft vasculopathy. , 2013, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.
[80] Joanna-Marie Howes. Proteomic profiling of plasma microparticles following deep-vein thrombosis , 2010, Expert review of proteomics.
[81] Ingo Ruczinski,et al. Statistical inference from multiple iTRAQ experiments without using common reference standards. , 2013, Journal of proteome research.
[82] Yurong Gu,et al. Serum proteomics analysis and comparisons using iTRAQ in the progression of hepatitis B , 2013, Experimental and therapeutic medicine.
[83] A. Rosenberg,et al. Low abundance protein enrichment for discovery of candidate plasma protein biomarkers for early detection of breast cancer. , 2011, Journal of proteomics.
[84] D. Dai,et al. Serum proteomics in multiple sclerosis disease progression. , 2015, Journal of proteomics.
[85] O. Krokhin,et al. The effects of infliximab therapy on the serum proteome of rheumatoid arthritis patients , 2009, Arthritis research & therapy.
[86] J. Yates,et al. Isobaric Labeling-Based Relative Quantification in Shotgun Proteomics , 2014, Journal of proteome research.
[87] S. Nie,et al. Isobaric protein-level labeling strategy for serum glycoprotein quantification analysis by liquid chromatography-tandem mass spectrometry. , 2013, Analytical chemistry.
[88] Yiping Huang,et al. Discovery of serum biomarkers implicated in the onset and progression of serous ovarian cancer in a rat model using iTRAQ technique. , 2012, European journal of obstetrics, gynecology, and reproductive biology.
[89] Sanjeeva Srivastava,et al. Differential expression of serum/plasma proteins in various infectious diseases: Specific or nonspecific signatures , 2013, Proteomics. Clinical applications.
[90] M. Rewers,et al. Temporal profiles of plasma proteome during childhood development. , 2017, Journal of proteomics.
[91] M. Westphall,et al. Gas-phase purification enables accurate, large-scale, multiplexed proteome quantification with isobaric tagging , 2011, Nature Methods.
[92] S. Laboissiere,et al. Serum proteomic approach for the identification of serum biomarkers contributed by oral squamous cell carcinoma and host tissue microenvironment. , 2009, Journal of proteome research.
[93] Frank Kjeldsen,et al. Undesirable charge-enhancement of isobaric tagged phosphopeptides leads to reduced identification efficiency. , 2010, Journal of proteome research.
[94] Martin Wühr,et al. A Strategy to Combine Sample Multiplexing with Targeted Proteomics Assays for High-Throughput Protein Signature Characterization. , 2017, Molecular cell.
[95] H. Saya,et al. Proteome profiling reveals gender differences in the composition of human serum , 2010, Proteomics.
[96] Pengyuan Yang,et al. Identification of transaldolase as a novel serum biomarker for hepatocellular carcinoma metastasis using xenografted mouse model and clinic samples. , 2011, Cancer letters.
[97] Mingshi Yang,et al. Identification of Potential Biomarkers by Serum Proteomics Analysis in Rats with Sepsis , 2014, Shock.
[98] Richard B. Thompson,et al. Gender‐specific plasma proteomic biomarkers in patients with Anderson–Fabry disease , 2015, European journal of heart failure.
[99] Pengyuan Yang,et al. Quantitative proteomic analysis of serum proteins in patients with Parkinson's disease using an isobaric tag for relative and absolute quantification labeling, two-dimensional liquid chromatography, and tandem mass spectrometry. , 2012, The Analyst.
[100] L. Puybasset,et al. Measuring Serum Amyloid A for Infection Prediction in Aneurysmal Subarachnoid Hemorrhage. , 2015, Journal of proteome research.
[101] R. Cole,et al. Maternal serum proteome changes between the first and third trimester of pregnancy in rural southern Nepal. , 2012, Placenta.
[102] D. Accili,et al. Altered Plasma Profile of Antioxidant Proteins as an Early Correlate of Pancreatic β Cell Dysfunction* , 2016, The Journal of Biological Chemistry.
[103] Jicheng Li,et al. Serum Protein KNG1, APOC3, and PON1 as Potential Biomarkers for Yin-Deficiency-Heat Syndrome , 2016, Evidence-based complementary and alternative medicine : eCAM.
[104] H. Fan,et al. iTRAQ-based Quantitative Proteomics Study in Patients with Refractory Mycoplasma pneumoniae Pneumonia. , 2017, Japanese journal of infectious diseases.
[105] Loïc Dayon,et al. Proteomic Biomarker Discovery in 1000 Human Plasma Samples with Mass Spectrometry. , 2016, Journal of proteome research.
[106] F. Pociot,et al. Plasma proteome analysis of patients with type 1 diabetes with diabetic nephropathy , 2010, Proteome Science.
[107] D. Goodlett,et al. The progress and potential of proteomic biomarkers for type 1 diabetes in children , 2017, Expert review of proteomics.
[108] Henry Brodaty,et al. Plasma protein profiling of Mild Cognitive Impairment and Alzheimer’s disease using iTRAQ quantitative proteomics , 2014, Proteome Science.
[109] Christoph H Borchers,et al. Multiplexed MRM‐based quantitation of candidate cancer biomarker proteins in undepleted and non‐enriched human plasma , 2013, Proteomics.
[110] S. Tannenbaum,et al. Comparative time-dependent analysis of potential inflammation biomarkers in lymphoma-bearing SJL mice. , 2007, Journal of proteome research.
[111] R. Lewensohn,et al. Use of narrow‐range peptide IEF to improve detection of lung adenocarcinoma markers in plasma and pleural effusion , 2009, Proteomics.
[112] Ming Yao,et al. SWATH™- and iTRAQ-based quantitative proteomic analyses reveal an overexpression and biological relevance of CD109 in advanced NSCLC. , 2014, Journal of proteomics.
[113] N. Anderson,et al. The Human Plasma Proteome , 2002, Molecular & Cellular Proteomics.
[114] A. V. D. Van Der Zee,et al. A panel of regulated proteins in serum from patients with cervical intraepithelial neoplasia and cervical cancer. , 2014, Journal of proteome research.
[115] H. Upur,et al. Identification of plasma protein markers common to patients with malignant tumour and Abnormal Savda in Uighur medicine: a prospective clinical study , 2015, BMC Complementary and Alternative Medicine.
[116] F. Guillonneau,et al. Serum profile in preeclampsia and intra-uterine growth restriction revealed by iTRAQ technology. , 2010, Journal of proteomics.
[117] G. Chrousos,et al. Whole serum 3D LC-nESI-FTMS quantitative proteomics reveals sexual dimorphism in the milieu intérieur of overweight and obese adults. , 2014, Journal of proteome research.
[118] Wei Ma,et al. Comprehensive maternal serum proteomics identifies the cytoskeletal proteins as non-invasive biomarkers in prenatal diagnosis of congenital heart defects , 2016, Scientific Reports.
[119] R. Christopherson,et al. Protein profiles distinguish stable and progressive chronic lymphocytic leukemia , 2016, Leukemia & lymphoma.
[120] Lloyd M. Smith,et al. Proteoform: a single term describing protein complexity , 2013, Nature Methods.
[121] Dhanashree S. Kelkar,et al. Proteomic Signature of Endothelial Dysfunction Identified in the Serum of Acute Ischemic Stroke Patients by the iTRAQ-Based LC-MS Approach. , 2015, Journal of proteome research.
[122] Han-Zhong Li,et al. iTRAQ-Based Quantitative Proteomic Analysis Identified HSC71 as a Novel Serum Biomarker for Renal Cell Carcinoma , 2015, BioMed research international.
[123] K. Shedden,et al. Mass-Selected Site-Specific Core-Fucosylation of Serum Proteins in Hepatocellular Carcinoma. , 2015, Journal of proteome research.
[124] C. Lynch,et al. Apolipoprotein A‐IV, a Putative Satiety/Antiatherogenic Factor, Rises After Gastric Bypass , 2009, Obesity.
[125] Janne Lehtiö,et al. Mass spectrometry-based plasma proteomics: state of the art and future outlook , 2014, Expert review of proteomics.
[126] Duan Ma,et al. Quantitative Proteomic Analysis of Serum from Pregnant Women Carrying a Fetus with Conotruncal Heart Defect Using Isobaric Tags for Relative and Absolute Quantitation (iTRAQ) Labeling , 2014, PloS one.
[127] S. Michelland,et al. Peptides OFFGEL electrophoresis: a suitable pre-analytical step for complex eukaryotic samples fractionation compatible with quantitative iTRAQ labeling , 2008, Proteome Science.
[128] J. Russo,et al. Alterations in the Rat Serum Proteome Induced by Prepubertal Exposure to Bisphenol A and Genistein , 2014, Journal of proteome research.
[129] Daniel G. Jamieson,et al. Detection of candidate biomarkers of prostate cancer progression in serum: a depletion-free 3D LC/MS quantitative proteomics pilot study , 2016, British Journal of Cancer.
[130] Minoru Fujimoto,et al. iTRAQ-based proteomic identification of leucine-rich α-2 glycoprotein as a novel inflammatory biomarker in autoimmune diseases , 2009, Annals of the rheumatic diseases.
[131] A. J. Markvoort,et al. Proteomic Analysis in Type 2 Diabetes Patients before and after a Very Low Calorie Diet Reveals Potential Disease State and Intervention Specific Biomarkers , 2014, PloS one.
[132] Ping Xu,et al. A Pro-Atherogenic HDL Profile in Coronary Heart Disease Patients: An iTRAQ Labelling-Based Proteomic Approach , 2014, PloS one.
[133] Edward L. Huttlin,et al. Increasing the multiplexing capacity of TMTs using reporter ion isotopologues with isobaric masses. , 2012, Analytical chemistry.
[134] Y. Takasaki,et al. Serum Proteome Analysis in Patients with Rheumatoid Arthritis Receiving Therapy with Tocilizumab: An Anti-Interleukin-6 Receptor Antibody , 2013, BioMed research international.
[135] Kelly A. Jones,et al. Immunodepletion plasma proteomics by tripleTOF 5600 and Orbitrap elite/LTQ-Orbitrap Velos/Q exactive mass spectrometers. , 2013, Journal of proteome research.
[136] Maoshan Chen,et al. iTRAQ-Based Proteomics Identification of Serum Biomarkers of Two Chronic Hepatitis B Subtypes Diagnosed by Traditional Chinese Medicine , 2016, BioMed research international.
[137] Yuling Chen,et al. Identification of Potential Serum Biomarkers for Rheumatoid Arthritis by High-Resolution Quantitative Proteomic Analysis , 2014, Inflammation.
[138] Yin-kun Liu,et al. Discovering potential serological biomarker for chronic Hepatitis B Virus-related hepatocellular carcinoma in Chinese population by MAL-associated serum glycoproteomics analysis , 2017, Scientific Reports.
[139] N. Oreiro,et al. Identification of a panel of novel serum osteoarthritis biomarkers. , 2011, Journal of proteome research.
[140] W. Sui,et al. Quantitative proteomic analysis of Down syndrome in the umbilical cord blood using iTRAQ. , 2015, Molecular medicine reports.
[141] Qiang Gao,et al. Oxidative stress induced carbonylation in human plasma. , 2011, Journal of proteomics.
[142] J. Michel,et al. ApoA-I/HDL-C levels are inversely associated with abdominal aortic aneurysm progression , 2015, Thrombosis and Haemostasis.
[143] Development of Serum Glycoproteomic Profiling Technique; Simultaneous Identification of Glycosylation Sites and Site-Specific Quantification of Glycan Structure Changes* , 2010, Molecular & Cellular Proteomics.
[144] J. Yates,et al. Direct analysis of protein complexes using mass spectrometry , 1999, Nature Biotechnology.
[145] L. Lang,et al. iTRAQ-based proteomic profiling of human serum reveals down-regulation of platelet basic protein and apolipoprotein B100 in patients with hematotoxicity induced by chronic occupational benzene exposure. , 2012, Toxicology.
[146] Jicheng Li,et al. Screening and identification of five serum proteins as novel potential biomarkers for cured pulmonary tuberculosis , 2015, Scientific Reports.
[147] S. Gygi,et al. MS3 eliminates ratio distortion in isobaric labeling-based multiplexed quantitative proteomics , 2011, Nature Methods.
[148] M. Loh,et al. Reduced plasma APOA1 level is associated with gastric tumor growth in MKN45 mouse xenograft model. , 2010, Journal of proteomics.
[149] Christoph H. Borchers,et al. Proteomic Signatures in Plasma during Early Acute Renal Allograft Rejection* , 2010, Molecular & Cellular Proteomics.
[150] Q. Shan,et al. Quantitative proteomic analysis by iTRAQ for identification of candidate biomarkers in plasma from acute respiratory distress syndrome patients. , 2013, Biochemical and biophysical research communications.
[151] Chuan Wang,et al. The Potential Role of ORM2 in the Development of Colorectal Cancer , 2012, PloS one.
[152] A. Skubitz,et al. Quantitative proteomic analysis by iTRAQ® for the identification of candidate biomarkers in ovarian cancer serum , 2010, Proteome Science.
[153] H. Gendelman,et al. Changes in the plasma proteome follows chronic opiate administration in simian immunodeficiency virus infected rhesus macaques. , 2012, Drug and alcohol dependence.
[154] B. Roschitzki,et al. Discovery of serum proteomic biomarkers for prediction of response to infliximab (a monoclonal anti-TNF antibody) treatment in rheumatoid arthritis: an exploratory analysis. , 2012, Journal of proteomics.
[155] Richard D. Smith,et al. IgY14 and SuperMix immunoaffinity separations coupled with liquid chromatography-mass spectrometry for human plasma proteomics biomarker discovery. , 2012, Methods.
[156] Juncong Yang,et al. MRM‐based multiplexed quantitation of 67 putative cardiovascular disease biomarkers in human plasma , 2012, Proteomics.
[157] A. Galande,et al. Serum biomarkers reveal long-term cardiac injury in isoproterenol-treated African green monkeys. , 2013, Journal of proteome research.
[158] Aditi Chatterjee,et al. Plasma Proteome Database as a resource for proteomics research: 2014 update , 2013, Nucleic Acids Res..
[159] Jason Liao,et al. Proteomic profiling of human plasma by iTRAQ reveals down-regulation of ITI-HC3 and VDBP by cigarette smoking. , 2011, Journal of proteome research.
[160] Investigation of ovarian cancer associated sialylation changes in N-linked glycopeptides by quantitative proteomics , 2012, Clinical Proteomics.
[161] R. Cole,et al. Global Screening of Human Cord Blood Proteomes for Biomarkers of Toxic Exposure and Effect , 2008, Environmental health perspectives.
[162] M. Loh,et al. ITIH3 is a potential biomarker for early detection of gastric cancer. , 2010, Journal of proteome research.
[163] Xiaoyan Zhang,et al. Altered protein expression in serum from endometrial hyperplasia and carcinoma patients , 2011, Journal of hematology & oncology.
[164] A. V. D. Van Der Zee,et al. Influence of clotting time on the protein composition of serum samples based on LC-MS data. , 2009, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.
[165] Ishtiaq Rehman,et al. iTRAQ underestimation in simple and complex mixtures: "the good, the bad and the ugly". , 2009, Journal of proteome research.
[166] F. Regnier,et al. Differential carbonylation of proteins as a function of in vivo oxidative stress. , 2011, Journal of proteome research.
[167] David R. Goodlett,et al. Quantitative Mass Spectrometry Analysis Using PAcIFIC for the Identification of Plasma Diagnostic Biomarkers for Abdominal Aortic Aneurysm , 2011, PloS one.
[168] Xinyu Zhao,et al. Complementary serum proteomic analysis of autoimmune hepatitis in mice and patients , 2013, Journal of Translational Medicine.
[169] B. McManus,et al. Molecular signatures of end-stage heart failure. , 2011, Journal of cardiac failure.
[170] T. Kondo,et al. Quantitative proteomic analysis identified paraoxonase 1 as a novel serum biomarker for microvascular invasion in hepatocellular carcinoma. , 2013, Journal of Proteome Research.
[171] Phillip C. Wright,et al. An insight into iTRAQ: where do we stand now? , 2012, Analytical and Bioanalytical Chemistry.
[172] Qing Yang,et al. Identification of GlcNAcylated alpha-1-antichymotrypsin as an early biomarker in human non-small-cell lung cancer by quantitative proteomic analysis with two lectins , 2016, British Journal of Cancer.
[173] Lanping Xu,et al. Ceruloplasmin Is a Potential Biomarker for aGvHD following Allogeneic Hematopoietic Stem Cell Transplantation , 2013, PloS one.
[174] Jicheng Li,et al. Serum protein S100A9, SOD3, and MMP9 as new diagnostic biomarkers for pulmonary tuberculosis by iTRAQ‐coupled two‐dimensional LC‐MS/MS , 2015, Proteomics.
[175] Jicheng Li,et al. A Group of Novel Serum Diagnostic Biomarkers for Multidrug-Resistant Tuberculosis by iTRAQ-2D LC-MS/MS and Solexa Sequencing , 2016, International journal of biological sciences.
[176] Diederick E Grobbee,et al. Searching for early breast cancer biomarkers by serum protein profiling of pre-diagnostic serum; a nested case-control study , 2011, BMC Cancer.
[177] K. Parker,et al. Multiplexed Protein Quantitation in Saccharomyces cerevisiae Using Amine-reactive Isobaric Tagging Reagents*S , 2004, Molecular & Cellular Proteomics.
[178] Michael J. Walker,et al. A Label-free Selected Reaction Monitoring Workflow Identifies a Subset of Pregnancy Specific Glycoproteins as Potential Predictive Markers of Early-onset Pre-eclampsia* , 2013, Molecular & Cellular Proteomics.
[179] S. Cross,et al. iTRAQ Identification of Candidate Serum Biomarkers Associated with Metastatic Progression of Human Prostate Cancer , 2012, PloS one.
[180] Hwee Tong Tan,et al. Proteomics discovery of biomarkers for mitral regurgitation caused by mitral valve prolapse. , 2013, Journal of proteomics.
[181] G. Siuzdak,et al. Quantitative plasma proteomic profiling identifies the vitamin E binding protein afamin as a potential pathogenic factor in SIV induced CNS disease. , 2010, Journal of proteome research.
[182] K. Lilley,et al. Identification of protein biomarkers in human serum using iTRAQ and shotgun mass spectrometry. , 2013, Methods in molecular biology.
[183] Matthias Mann,et al. Plasma Proteome Profiling to Assess Human Health and Disease. , 2016, Cell systems.
[184] A. Xu,et al. Lower Fetuin-A, Retinol Binding Protein 4 and Several Metabolites after Gastric Bypass Compared to Sleeve Gastrectomy in Patients with Type 2 Diabetes , 2014, PloS one.
[185] Quantification of Serum Proteins of Metastatic Oral Cancer Patients Using LC-MS/MS and iTRAQ Labeling. , 2008, The open proteomics journal.
[186] Kunzheng Wang,et al. Comparative study of serum proteomes in Legg-Calve-Perthes disease , 2015, BMC Musculoskeletal Disorders.
[187] Arunangshu Das,et al. Proteomic profiling of human plasma identifies apolipoprotein E as being associated with smoking and a marker for squamous metaplasia of the lung , 2015, Proteomics.
[188] Proteomic profiling for the identification of serum diagnostic biomarkers for abdominal and thoracic aortic aneurysms , 2013, Proteome Science.
[189] Johan Lindberg,et al. A systems biology approach to understanding elevated serum alanine transaminase levels in a clinical trial with ximelagatran , 2009, Biomarkers : biochemical indicators of exposure, response, and susceptibility to chemicals.
[190] J. Kellum,et al. Additions to the Human Plasma Proteome via a Tandem MARS Depletion iTRAQ-Based Workflow , 2013, International journal of proteomics.
[191] J. van der Greef,et al. The art and practice of systems biology in medicine: mapping patterns of relationships. , 2007, Journal of proteome research.
[192] Establishment of a Strategy for the Discovery and Verification of Low-Abundance Biomarker Peptides in Plasma Using Two Types of Stable-Isotope Tags. , 2014, Mass spectrometry.
[193] Ruedi Aebersold,et al. Quantitative variability of 342 plasma proteins in a human twin population , 2015 .
[194] H. Li,et al. Screening differential expression of serum proteins in AFP-negative HBV-related hepatocellular carcinoma using iTRAQ -MALDI-MS/MS. , 2013, Neoplasma.
[195] Hasmik Keshishian,et al. Multiplexed, Quantitative Workflow for Sensitive Biomarker Discovery in Plasma Yields Novel Candidates for Early Myocardial Injury* , 2015, Molecular & Cellular Proteomics.
[196] S. Sze,et al. Data for iTRAQ profiling of micro-vesicular plasma specimens: In search of potential prognostic circulatory biomarkers for Lacunar infarction , 2015, Data in brief.
[197] B. McManus,et al. Proteomic biomarkers of recovered heart function , 2014, European journal of heart failure.
[198] E. Gamelin,et al. A Proteomic Approach for Plasma Biomarker Discovery with iTRAQ Labelling and OFFGEL Fractionation , 2009, Journal of biomedicine & biotechnology.
[199] N. Anderson,et al. A List of Candidate Cancer Biomarkers for Targeted Proteomics , 2006, Biomarker insights.
[200] H. Isoniemi,et al. Relative Quantification of Several Plasma Proteins during Liver Transplantation Surgery , 2011, Journal of biomedicine & biotechnology.
[201] D. Gozal,et al. Serum proteomic changes in adults with obstructive sleep apnoea , 2012, Journal of sleep research.
[202] S. Sreevatsan,et al. Biomarker Discovery in Subclinical Mycobacterial Infections of Cattle , 2009, PloS one.
[203] Jicheng Li,et al. Discovery and identification of serum potential biomarkers for pulmonary tuberculosis using iTRAQ‐coupled two‐dimensional LC‐MS/MS , 2014, Proteomics.
[204] H. Friess,et al. iTRAQ reveals candidate pancreatic cancer serum biomarkers: influence of obstructive jaundice on their performance , 2013, British Journal of Cancer.
[205] M. Dunn,et al. A comparison of the bovine uterine and plasma proteome using iTRAQ proteomics , 2012, Proteomics.
[206] Hongtao Li,et al. Discovery and verification of serum differential expression proteins for pulmonary tuberculosis. , 2015, Tuberculosis.
[207] R. Buckanovich,et al. Identification and confirmation of differentially expressed fucosylated glycoproteins in the serum of ovarian cancer patients using a lectin array and LC-MS/MS. , 2012, Journal of proteome research.
[208] Eithne Costello,et al. Analysis of serum proteins by LC-MS/MS. , 2010, Methods in molecular biology.
[209] Chi Bun Ching,et al. VKORC1 Pharmacogenetics and Pharmacoproteomics in Patients on Warfarin Anticoagulant Therapy: Transthyretin Precursor as a Potential Biomarker , 2010, PloS one.
[210] S. Fisher,et al. Evaluating the effects of preanalytical variables on the stability of the human plasma proteome. , 2015, Analytical biochemistry.
[211] Kunzheng Wang,et al. Serum Proteomic Analysis Based on iTRAQ in Miners Exposed to Soil Containing Rare Earth Elements , 2015, Biological Trace Element Research.
[212] S. Walsh,et al. The serum proteome of nonalcoholic fatty liver disease: A multimodal approach to discovery of biomarkers of nonalcoholic steatohepatitis , 2014, Journal of gastroenterology and hepatology.
[213] Michael J. Walker,et al. Protein Z: A putative novel biomarker for early detection of ovarian cancer , 2016, International journal of cancer.
[214] Michelle A. Anderson,et al. Quantitative Analysis of Single Amino Acid Variant Peptides Associated with Pancreatic Cancer in Serum by an Isobaric Labeling Quantitative Method , 2014, Journal of proteome research.
[215] L. Boulet,et al. Plasma proteomics can discriminate isolated early from dual responses in asthmatic individuals undergoing an allergen inhalation challenge , 2012, Proteomics. Clinical applications.
[216] Mack T. Ruffin,et al. Glycoprotein Biomarker Panel for Pancreatic Cancer Discovered by Quantitative Proteomics Analysis , 2014, Journal of proteome research.
[217] D. Formanowicz,et al. iTRAQ-based proteomic analysis of plasma reveals abnormalities in lipid metabolism proteins in chronic kidney disease-related atherosclerosis , 2016, Scientific Reports.
[218] A. Secord,et al. Autoantibody biomarkers identified by proteomics methods distinguish ovarian cancer from non-ovarian cancer with various CA-125 levels , 2013, Journal of Cancer Research and Clinical Oncology.
[219] M. Kussmann,et al. Proteomics of human plasma: A critical comparison of analytical workflows in terms of effort, throughput and outcome , 2013 .
[220] R. Lewensohn,et al. Evaluation of three principally different intact protein prefractionation methods for plasma biomarker discovery. , 2008, Journal of proteome research.
[221] P. Hu,et al. The role of von Willebrand factor as a biomarker of tumor development in hepatitis B virus-associated human hepatocellular carcinoma: a quantitative proteomic based study. , 2014, Journal of proteomics.
[222] M. Harel,et al. Proteomics of Microparticles with SILAC Quantification (PROMIS-Quan): A Novel Proteomic Method for Plasma Biomarker Quantification* , 2015, Molecular & Cellular Proteomics.